Model 5 (>15% Methylation Change and Inversely Correlated) | Model 6 (>15% .Methylation Change) | Model 7 (>15% Methylation Change, Significances Combined) | Model 8 (>15% Methylation Change, Inverse Correlated,Significances Combined) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KEGG TERMs | A | B | C | D | A | B | C | D | A | B | C | D | A | B | C | D |
MAPK Signalling | - | - | - | 45 | 16 | 3 | 2 | 2 | 29 | 4 | 8 | 6 | - | - | - | 59 |
ECM Receptor | 14 | - | 28 | 6 | 8 | - | 35 | 3 | 3 | 10 | 3 | 3 | 18 | - | 34 | 7 |
ErbB Signalling | - | 15 | 13 | 5 | 26 | 6 | 7 | 7 | 28 | 8 | 13 | 10 | 31 | 3 | 4 | 4 |
NF-KB Signalling | 22 | - | 35 | 29 | 18 | - | 41 | 31 | 20 | - | 39 | 22 | 5 | - | 19 | 11 |
Wnt-β-Catenin Signalling | 21 | - | 34 | 72 | 64 | 28 | 40 | 46 | 51 | - | 62 | 72 | - | - | - | - |
VEGF Signalling | 25 | 24 | 17 | 51 | 44 | 34 | 36 | 37 | 50 | 30 | 33 | 30 | 34 | 21 | 17 | 60 |
Thyroid Cancer | 28 | 14 | 15 | 88 | 32 | 27 | 22 | 106 | 39 | 20 | 22 | 45 | 28 | 17 | 13 | 65 |
Adherens Junction | 9 | 8 | 5 | 7 | 25 | 24 | 15 | 6 | 26 | 7 | 9 | 14 | 8 | - | 24 | 10 |
p53 Signalling | - | - | - | 26 | - | - | - | 80 | 40 | - | 50 | 54 | - | - | - | 25 |
TGF-beta Signalling | - | - | - | 12 | 41 | 32 | 32 | 9 | 10 | 3 | 4 | 13 | - | - | - | - |
Notch Signalling | 5 | 9 | 2 | 49 | - | 4 | 26 | 24 | 54 | 18 | 28 | 12 | - | 22 | 50 | 55 |
GnRH Signalling | - | 6 | 23 | 21 | 19 | 33 | 21 | 40 | - | 41 | 78 | 56 | 2 | - | 8 | 37 |
Neurotrophin Signalling | 7 | 2 | 3 | 15 | 15 | 14 | 8 | 12 | 13 | 13 | 7 | 17 | 20 | - | 36 | 21 |
Focal Adhesion | 4 | - | 16 | 1 | 3 | 17 | 4 | 1 | 1 | 6 | 2 | 2 | 7 | - | 23 | 2 |
Transcr. Misregulation | - | - | - | 40 | 30 | - | 48 | 77 | 58 | - | 68 | 51 | - | - | - | 65 |
Apoptosis | 2 | - | 7 | 8 | 20 | - | 42 | 20 | 6 | - | 27 | 4 | 25 | - | 38 | 1 |
Pathways in Cancer | 3 | - | 8 | 3 | 1 | 1 | 1 | 8 | 2 | 1 | 1 | 1 | 3 | - | 11 | 3 |
Toll-like receptor signalling pathway | - | - | - | 75 | - | - | - | - | - | - | - | 8 | - | - | - | 5 |
Pentose-phosphate pathway | 18 | 12 | 10 | 25 | - | 30 | 64 | - | 34 | 31 | 29 | 18 | 4 | - | 14 | 17 |